Strategies for antenatal detection of Down's syndrome

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 76, Issue 1, 1997, Pages

  Wyllie, Jonathan P ^a   Madar, R John ^a   Wright, Michael ^a   Burn, John ^a   Wren, Christopher ^a,b  

^a N Reg Congenital Abnormal Survey

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Down's syndrome; Maternal serum screening; Screening

Indexed keywords

ARTICLE; CHILD; DOWN SYNDROME; ECHOCARDIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THEORY;

EID: 0031398427     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.76.1.F26     Document Type: Article

References (24)

1. Haddow JE, Polamaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
2. Beekhuis JR, Wolf BTHM, Mantingh A, Heringa MP. The influence of serum screening on the amniocentesis rate in women of advanced maternal age. Prenat Diagn 1994;14:199-202.
3. Platt LD, Carlson DE. Prenatal diagnosis - when and how? N Engl J Med 1992;327:367-8.
4. Youings S, Gregson N, Jacobs P. The efficacy of maternal age screening for Down's syndrome in Wessex. Prenat Diagn 1991;11:419-25.
5. Wald N, Wald K, Smith D. The extent of Down's syndrome screening in Britain in 1991. Lancet 1992;340:494.
6. Pauker SP, Pauker SG. Prenatal diagnosis - why is 35 a magic number? N Engl J Med 1994;330:1151-2.
7. Smith DK, Shaw RW, Marteau T. Informed consent to undergo serum screening for Down's syndrome: The gap between policy and practice. BMJ 1994;309:776.
8. Green JM. Serum screening for Down's syndrome: Experiences of obstetricians in England and Wales. BMJ 1992;309:769-72.
9. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992;305:391-4.
10. Stoll C, Dott B, Alembik Y, Roth M. Evaluation of routine prenatal ultrasound examination in detecting fetal chromosomal abnormalities in a low risk population. Hum Genet 1993;91:37-41.
11. Lockwood CJ, Lynch L, Berkowitz RL. Ultrasonographic screening for the Down syndrome fetus. Am J Obstet Gynecol 1991;165:349-52.
12. Northern Regional Health Authority Co-ordinating Group. Perinatal mortality: a continuing collaborative regional survey. BMJ 1984;288:1717-20.
13. Northern Regional Survey Steering Group. Fetal abnormality: an audit of its recognition and management. Arch Dis Child 1992;67:F770-4.
14. Abu-Harb M, Wyllie J, Hey E, Richmond S, Wren C. Antenatal diagnosis of congenital heart disease and Down's syndrome: the potential effect on the practice of paediatric cardiology. Br Heart J 1995;74:192-8.
15. Cornel MC, Breed ASPM, Beekhuis JR, Meerman GJ, Kate LP. Down syndrome: effects on demographic factors and prenatal diagnosis on the future livebirth prevalence. Hum Genet 1993;92:163-8.
16. Crossley JA, Aitken DA, Berry E, Connor JM. Impact of a regional screening programme using maternal serum α fetoprotein (AFP) and human chorionic gondotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland. J Med Screen 1994;1:180-3.
17. Sharland GK, Lockhart SM, Chita SK, Allan LD. Factors influencing the outcome of congenital heart disease detected prenatally. Arch Dis Child 1991;66:284-7.
18. Wyllie JP, Wren C, Hunter S. Screening for fetal cardiac malformations. Br Heart J 1994;71(suppl):20-7.
19. McGrother CW, Marshall B. Recent trends in incidence, morbidity and survival in Down's syndrome. J Mental Deficiency Res 1990;34:49-57.
20. Alberman E, Mutton D, Ide R, Nicholson A, Bobrow M. Down's syndrome births and pregnancy terminations in 1989 to 1993: preliminary findings. Br J Obstet Gynaecol 1995;102:445-7.
21. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age and older with serum markers for screening. N Engl J Med 1994;330:1114-8.
22. Fletcher J, Hicks NR, Kay JDS, Boyd PA. Using decision analysis to compare policies for antenatal screening for Down's syndrome. BMJ 1995;311:351-6.
23. Hook EB, Topol BB, Cross PK. The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are nor terminated electively: new data and estimates of excess and relative risk of late fetal death associated with 47, +21 and some other abnormal karyotypes. Am J Hum Genet 1989;45:855-61.
24. Matilainen R, Airaksinen E, Mononen T, Launiala K, Kaariainen R. A population-based study on the causes of mild and severe mental retardation. Acta Paediatr 1995;84:261-6.